Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | INMBInmune Bio Inc.FY2025 · Dec |
|---|---|
| Revenue | $50.00K |
| Revenue, yoy | +257.1% |
| Net income | $45.93M |
| Net income, yoy | −9.2% |
| Net margin | -91,866.0% |
| Free cash flow | $23.62M |
| FCF margin | -47,248.0% |
| EPS, diluted | $1.86 |
Add another company.